Company page

Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. (Ticker: RCKT) is a public company based in the United States, with a market capitalization of approximately $365.8 million. The company focuses on developing innovative gene therapies for rare genetic diseases. Rocket Pharmaceuticals is committed to advancing its pipeline of treatments to address unmet medical needs in the field of genetic disorders.